Document:

EX-10.1

 Exhibit 10.1 

ENTEROMEDICS INC. 

EXECUTIVE EMPLOYMENT AGREEMENT 

THIS AGREEMENT (the “Agreement”) is made and entered on October 28, 2015 (the “Agreement Date”), between ENTEROMEDICS
INC. (“Company”), a Delaware corporation with its principal place of business at 2800 Patton Road, St. Paul, Minnesota 55113; and DAN W. GLADNEY (“Employee”), a Minnesota resident whose address is 100 Third Ave. So., Unit 2202,
Minneapolis, MN 55401, for the purpose of setting forth the terms and conditions of Employee’s employment by Company, effective November 2, 2015. 

BACKGROUND 
 WHEREAS, Employee
possesses certain skills, talents, contacts, judgment and knowledge of the business of Company; 
 WHEREAS, Employee has been offered the
position of Chief Executive Officer and President by Company, and Company desires to have the benefit of Employee’s employment in such capacities, and Employee desires to serve in such capacities, pursuant to the terms and conditions set forth
in this Agreement; and 
 WHEREAS, Employee understands that his employment by Company is expressly conditioned on execution of this
Agreement. 
 AGREEMENT 
 NOW,
THEREFORE, in consideration of Employee’s employment with Company and the facts recited above, the mutual covenants set forth below and other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged,
Company and Employee agree as follows: 
 ARTICLE I. EMPLOYMENT, TERM AND DUTIES 

1.1. Employment. Company hereby employs Employee as its Chief Executive Officer and President, and Employee accepts such employment and agrees to
perform services for Company pursuant to the terms and conditions set forth in this Agreement. 
 1.2. Term. The term (the “Term”) of this
Agreement shall commence on the Agreement Date and, unless earlier terminated in accordance with Article III of this Agreement, shall terminate two years from the Agreement Date; provided, however, that the Term of this Agreement shall
automatically renew for successive one year terms thereafter unless, at least 90 days before the expiration of the initial Term or any additional Term, either party provides written notice to the other of its or his desire to terminate this
Agreement. 
 1.3. Position and Duties. 

1.3.1. Service with Company. During the Term, Employee agrees to perform such duties and responsibilities, consistent with the duties
normally performed by chief executive officers of similarly-sized publicly-held companies, as are assigned to him from time to time by Company’s Board of Directors (the “Board”). 

1.3.2. Performance of Duties. During the Term, Employee agrees to serve Company in an executive capacity as its President and Chief
Executive Officer, and shall perform such duties as are required by Company’s Board of Directors, as set forth in Section 1.3.1. 

 ARTICLE II. COMPENSATION, BENEFITS AND EXPENSES 

2.1. Base Salary. Subject to the provisions of Article III of this Agreement, during the Term, Company shall pay Employee a “Base Salary”
not less than $475,000 per year or such higher annual rate as may from time to time be approved by the Board. Such Base Salary shall be paid in substantially equal regular periodic payments, less deductions and withholdings, in accordance with
Company’s regular payroll procedures, policies and practices for executive officers, as such may be modified from time to time. The Base Salary shall be reviewed by the Board annually for potential adjustment on the basis of performance; and
Employee shall be eligible, at Company’s sole discretion, for annual salary increases consistent with Company’s procedures, policies and practices. If Employee’s Base Salary is increased from time to time during the Term, the
increased amount shall become the Base Salary for the remainder of the Term and any extensions of the Term and for as long thereafter as required pursuant to Article III as applicable, subject to any subsequent increases. 

2.2. Incentive Compensation. In addition to Base Salary, Company shall make Employee eligible for such cash and equity awards pursuant to
Company’s Incentive Compensation Plan, if any, as may be applicable and adopted by Company. Except to the extent as otherwise provided in Article III in connection with a termination of Employee’s employment, Employee will be eligible
for an annual maximum management incentive program (“MIP”) bonus of up to 50% of his Base Salary in effect from time to time based on his level of achievement of milestones established between him and the Compensation Committee of the
Board. Employee and the Compensation Committee will meet and review the objectives set by the Compensation Committee for each upcoming calendar year before March 31 of such year. Company shall pay any such incentive compensation earned by
Employee for a calendar year on or before March 15 of the following year. 
 2.3. Stock Options. Executive will be granted an option to purchase
7,750,000 shares of the Company’s common stock, which is intended to represent 5.0% of the Company’s fully diluted outstanding shares, as adjusted, as of the date of grant of such stock option (including outstanding options and warrants
and shares issued pursuant to Company’s Stock Incentive Plan (the “Stock Plan”)). The Company will register the exercise of the stock option under the Securities Act of 1933, as amended, on a Form S-8 Registration Statement within 60
days of the date of grant, and the exercise price of such stock option will be equal to the fair market value of the Common Stock as of the date of option grant, as determined by the Board. Such stock option will be subject to vesting as follows:
25% will vest as of one year from the Agreement Date, and the remaining 75% of the shares will then vest in equal 2.0833% installments each month thereafter over the following 36 months. 

  
 2 

 2.4. Participation in Benefits. During the Term of Employee’s employment by Company, Employee shall
be entitled to participate in the employee benefits offered generally by Company to its employees, to the extent that Employee’s position, tenure, salary, health and other qualifications make Employee eligible to participate. Without limiting
the foregoing, Employee shall be eligible to participate in any pension plan, or group life, health or accident insurance or any other plan or policy that may presently be in effect or that may hereafter be adopted by Company for the benefit of its
employees and/or corporate officers generally. Employee is eligible to receive six weeks of vacation on an annual basis, subject to Company’s “Paid Time Off” policy. Employee’s participation in such benefits shall be subject to
the terms of the applicable plans, as the same may be amended from time to time. Except for the terms of the compensation and benefits set forth in Sections 2.1, 2.2 and 2.3, Company does not guarantee the adoption or continuance of any particular
employee benefit during Employee’s employment; and nothing in this Agreement is intended to, or shall in any way restrict the right of Company to amend, modify or terminate any of its benefit plans during the Term of this Agreement. 

ARTICLE III. TERMINATION AND COMPENSATION FOLLOWING TERMINATION 

3.1. Termination. Subject to the respective continuing obligations of the parties under this Agreement, this Agreement and Employee’s employment
hereunder may be terminated as of the applicable date, whether before or at the end of the Term (the “Separation Date”) under any of the following circumstances: 

3.1.1. Termination by Mutual Agreement. By mutual written agreement of the parties at any time, which may specify a Separation Date.

 3.1.2. Termination by Employee’s Death. If Employee dies during the Term, the date of his death shall be his Separation Date.

 3.1.3. Termination Due to Employee’s Disability. If Employee becomes Disabled, the Separation Date shall be the effective
date of his resignation or his discharge by the Company because of the Disability, whichever occurs first. For purposes of this Agreement, “Disabled” or “Disability” means the incapacity or inability of Employee, whether due to
accident, sickness or otherwise (with the exception of the illegal use of drugs), to perform the essential functions of Employee’s position under this Agreement, with or without reasonable accommodation (provided that no accommodation that
imposes undue hardship on Company will be required) for an aggregate of 90 days during any period of 180 consecutive days, or such longer period as may be required under applicable law. 

If Employee (or his legal representative, if applicable) does not agree with the Company’s decision to terminate his employment hereunder
because of Disability, the question of Employee’s Disability shall be subject to the certification of a qualified medical doctor mutually agreed to by Company and Employee (or, in the event of Employee’s incapacity to designate a doctor,
Employee’s legal representative). In the absence of such agreement, each such party shall nominate a qualified medical doctor and the two doctors shall select a third doctor, who shall make the determination as to Employee’s Disability.
The decision of the designated physician shall be binding upon the parties in the same manner as the decision of an arbitrator under Section 7.5. 

  
 3 

 3.1.4. Termination by Company for Cause. Company may terminate this Agreement and
Employee’s employment for Cause at any time after providing written notice to Employee. For purposes of this Agreement, “Cause” means: (a) willful breach of Employee’s duties to Company in any material respect (other than
any such failure resulting from Employee’s incapacity due to bodily injury or physical or mental illness) or willful breach of any material provision of this Agreement; (b) Employee’s conviction of any felony or any crime involving
fraud; (c) Employee’s willful participation in any fraud against or affecting Company or any subsidiary, affiliate, customer, supplier, client, agent, or employee thereof; or (d) any other act that constitutes gross or willful
misconduct materially detrimental to the Company, including, but not limited to, unethical practices, dishonesty, disloyalty, or any other acts harmful to Company; provided, however that a for Cause termination pursuant to clause (a), if
susceptible of cure, shall not become effective unless Employee fails to cure such failure to perform or breach within 30 days after his receipt of written notice from Company, such notice to describe such failure to perform or breach and
identity what reasonable actions shall be required to cure such failure to perform or breach. 
 For purposes of this Section 3.1.4, no
act, or failure to act, on Employee’s part shall be considered “dishonest” or “willful” unless done, or omitted to be done, by Employee in bad faith and without reasonable belief that his action or omission was in or not
opposed to, the best interest of Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or based upon the advice of counsel for Company shall be conclusively presumed to be done, or omitted
to be done, by Employee in good faith and in the best interests of Company. Furthermore, the term “Cause” shall not include ordinary negligence or failure to act, whether due to an error in judgment or otherwise, if Employee has exercised
substantial efforts in good faith to perform the duties reasonably assigned or appropriate to his position. 
 Notwithstanding the
foregoing, Employee will not be deemed to have been terminated for Cause unless and until there has been delivered to Employee a copy of a resolution, duly adopted by the affirmative vote of not less than a majority of the members of the Board at a
meeting of the Board (after 30 days’ prior written notice to Employee and an opportunity for Employee to be heard before the Board), stating that in the good faith opinion of the Board Employee was guilty of conduct constituting
“Cause” as set forth above and specifying the particulars thereof in reasonable detail. 
 3.1.5. Termination by Employee
without Good Reason. Employee may at any time voluntarily terminate his employment under this Agreement, for any reason or no reason, with 30 days written notice. 

3.1.6. Termination by Company without Cause. Company may terminate Employee’s employment under this Agreement at any time for any
reason or no reason with 30 days written notice, except that no notice shall be required for a termination without Cause following a “Change in Control” as defined in Employee’s Incentive Stock Option Agreement(s) or Non Incentive
Stock Option Agreement(s), as the case may be, with Company (collectively, the “Stock Option Agreements”). 

  
 4 

 3.1.7. Termination by Employee for Good Reason. Employee may at any time voluntarily
terminate his employment pursuant to this Agreement for Good Reason (as defined below); provided, however, that any resignation by Employee for Good Reason shall not be effective unless and until the following two conditions have been satisfied:
(a) he has notified Company in writing of the facts that he believes constitute Good Reason, within 90 days after such facts first becomes known to him; and (b) Company fails to cure such Good Reason within 30 days after its
receipt of that notice. Employee’s resignation shall be effective before the end of that 30 day period as of any earlier date on which Company refuses to cure or denies the existence of such Good Reason. The effective date of any
resignation for Good Reason shall be a Separation Date. If Company timely cures such Good Reason, or it is determined that the reason for Employee’s resignation was not a Good Reason, he shall be deemed not to have resigned unless he elects to
resign under Section 3.1.5. 
 For purposes of this Agreement, “Good Reason” means, at any time: (a) the assignment by
Company to Employee of employment duties, functions or responsibilities that are significantly different from, and result in a substantial diminution of, Employee’s duties, functions or responsibilities, including without limitation any
requirement that Employee report to another officer of Company, rather than directly to the Board; (b) a material reduction in Employee’s Base Salary or the minimum target amount provided under Section 2.2 for his cash incentive
compensation for any calendar year; (c) a Company requirement that Employee be based at any office or location more than 25 miles from Employee’s primary work location before the date of this Agreement; or (d) any other action or
inaction that constitutes a material breach of this Agreement by Company. 
 3.1.8. Termination at End of Term. The termination of
this Agreement and Employee’s employment, as of the end of the initial Term or any additional Term, pursuant to the operation of the provisions of Section 1.2, shall entitle Employee only to the payments provided in Sections 3.2.1 and
3.3. 
 3.2. Compensation following Termination of Employment. If Employee’s employment pursuant to this Agreement is terminated before the end
of the Term, or by Company as of the end of the Term, Employee shall be entitled to the following compensation and benefits upon such termination: 

3.2.1. Payment of Base of Salary. If Employee’s employment is terminated pursuant to any subsection of Section 3.1, Company
shall, within 14 calendar days following the Separation Date, pay to Employee, Employee’s surviving spouse (or, if none, Employee’s estate), as the case may be, any amounts due to Employee for Base Salary through the Separation Date. 

If a termination occurs pursuant to Section 3.l.5 (by Employee without Good Reason), when Company receives Employee’s notice Company
shall have the option, at its discretion (a) to continue to engage Employee’s services through the 30 day notice period until the Separation Date, or (b) terminate the use of Employee’s services during the 30 day notice
period 

  
 5 

 
before the Separation Date but treat Employee as if he were providing services through the 30 day notice period until the Separation Date for purposes of determining Employee’s
compensation due him pursuant to this Section 3.2.1. 
 3.2.2. Payment of Severance for Termination by Company without Cause or by
Employee for Good Reason. If (a) Employee’s employment is terminated pursuant to Sections 3.1.6 (by Company without Cause), 3.1.7 (by Employee for Good Reason), or 3.1.8 (Termination at End of Term), as a result of Company giving
notice to Employee of Company’s desire to terminate this Agreement, (b) Employee has executed and delivered to Company, within 60 days after the effective date of that termination, a written release in substantially the same term
attached hereto as Exhibit A, and (c) the rescission period specified therein has expired, (i) Company shall, subject to any payment delay required by Section 3.2.6, continue to pay, as severance pay, Employee’s Base Salary
(at the rate in effect on the Separation Date, for a period of 18 months following the Separation Date, (ii) 100% of any unvested shares under the Options shall immediately vest, and (iii) Employee shall be permitted to exercise all
shares under his Options immediately or at any time during the five year period (but not after the end of each Option’s original term) following the Separation Date. Such payments of Base Salary will be at the usual and customary pay intervals
of Company and will be subject to all appropriate deductions and withholdings. For purposes of Employee’s qualification for severance pay, his right to any series of such payments due under this Agreement is treated as the right to a series of
separate payments, each of which is subject to all of the requirements of this Section 3.2.2. 
 3.2.3. Effects of Change in
Control. Upon the occurrence of a Change in Control (as defined in Section 3.1.6), Company agrees that, notwithstanding any contrary provisions of the Stock Option Agreements or Company’s Stock Incentive Plan, the vesting schedule of
Employee’s stock options granted in the Stock Option Agreements (the “Options”) shall accelerate such that on the date the Change in Control is completed, 100% of any then unvested shares subject to the Options held by Employee shall
immediately vest; provided, however, that if, in connection with the consummation of the transaction resulting in the Change in Control, Employee receives a cash payment with respect to each Option (after they become fully vested) equal to the
difference or “spread’’ between (a) the per share amount paid to holders of Company’s common stock in such transaction and (b) the per share exercise price under the applicable Stock Option Agreement, his Options shall
be cancelled upon the consummation of the Change in Control in exchange for such cash payment; provided, further, that if in connection with or within the first two years after the Change in Control (as defined in Section 3.1.6),
Employee’s employment is terminated pursuant to either of Sections 3.1.6 (by Company without Cause) or 3.1.7 (by Employee for Good Reason), and (a) Employee has executed and delivered to Company, within 60 days after the
effective date of that termination, a written release in substantially the same form attached hereto as Exhibit A, and (b) the rescission period specified therein has expired, then, in addition to the payments under Section 3.2.2:

 (A) within 14 calendar days following the Separation Date, the Company shall also pay to Employee, or Employee’s surviving spouse
(or, if none, Employee’s estate), as the case may be) any amounts to which Employee is entitled as of the Separation Date, as a pro rata portion of any unpaid cash incentive compensation determined under Section 2.2 for the calendar year
in which the Separation Date occurs. That pro-rated cash incentive compensation shall be based on whether Employee’s objectives were achieved (also prorated to the extent possible) during the portion of the year before the Separation Date; and
the pro-rated amount shall be based on the number of days in that portion, as compared with the entire year; and 

  
 6 

 (B) the vesting schedule of Options held by Employee shall accelerate such that on the Separation
Date connected with or after a Change in Control, 100% of any unvested shares under the Options shall immediately vest and shall be exercisable immediately or at any time during the five year period (but not after the end of each Option’s
original term) following the Separation Date, notwithstanding any contrary provisions of the Stock Option Agreements or Company’s Stock Incentive Plan; provided, however, that if, in connection with the consummation of the transaction resulting
in the Change in Control, Employee receives a cash payment with respect to each Option (after they become fully vested under this paragraph) equal to the difference or “spread” between (a) the per share amount paid to holders of
Company’s common stock in such transaction and (b) the per share exercise price under the applicable Stock Option Agreement, his Options shall be cancelled upon the consummation of the Change in Control in exchange for such cash payment.
The parties hereto agree and acknowledge that, with respect to any Options previously granted to Employee that were intended by the parties to be treated as “incentive stock options” within the meaning of Code Section 422, such
Options, to the extent they may be exercised by Employee more than 90 days following the Separation Date, shall be treated as non-qualified Options, notwithstanding any contrary provisions of the Stock Option Agreements. 

3.2.4. General Provision Regarding Treatment of Options. Except as otherwise specified in Sections 3.2.2 and 3.2.4 of this
Agreement, the terms of the Stock Incentive Plan and Stock Option Agreements, as applicable, shall govern the treatment of the Options following the Separation Date. 

3.2.5. Code Section 409A. If, as of the Separation Date, (a) Company’s common stock is publicly traded (as determined
under Code Section 409A), (b) Employee is a “specified employee” (as determined under Code Section 409A), and (c) any portion of the severance pay due Employee under Sections 3.2.2, 3.2.3 (and, if applicable,
paragraph (A) of Section 3.2.4) would exceed the sum of all applicable exclusions as determined pursuant to Code Section 409A (and all rights to payments and benefits hereunder shall be treated as rights to receive a series of
separate payments and benefits to the fullest extent allowed by Code Section 409A), then payment of the excess amount that is deferred compensation under Code Section 409A shall be delayed until the first regular payroll date of Company
following the six month anniversary of Employee’s Separation Date (or the date of his death, if earlier than that anniversary), and shall include a lump sum equal to the aggregate amounts that Employee would have received had payment of this
excess amount commenced as provided in Sections 3.2.2, 3.2.3 (and, if applicable, paragraph (A) of Section 3.2.4) after the Separation Date. If Employee continues to perform any services for Company (as an employee or otherwise) after
the Separation Date, such six month period shall be measured from the date of Employee’s “separation from service” as defined pursuant to Code Section 409A. In addition to the foregoing, to the extent that any payment of deferred
compensation subject to Code Section 409A is contingent upon the execution of a written release, if the designated period for executing a written release spans two of the Employee’s tax years, the payment will be paid in the second tax
year. The Company and Employee intend that any termination of employment under this Agreement shall constitute and have the same meaning as “separation from service” as that phrase is defined under Code Section 409A and any Separation
Date shall be treated as occurring only upon a “separation from service.” 

  
 7 

 3.3. Benefits Following Certain Employment Terminations. If Employee’s employment is terminated
pursuant to any of Sections 3.1.2, 3.1.3, 3.1.6, 3.l.7 or 3.1.8, Company shall provide, at the sole cost of Company (except for any share of the cost for benefits of his spouse and eligible dependents that Employee was required to pay
immediately before the Separation Date), continuing coverage under any of its medical, dental and life insurance programs for Employee (if he survives) and his spouse and any eligible dependents, to the extent any such coverage was in effect for any
of those individuals immediately before the Separation Date, during the greater of the following periods: (a) if applicable, the period during which he is entitled to receive his Base Salary as severance pay under Section 3.2.2 or 3.2.3;
or (b) the first 18 months after the Separation Date, irrespective of any then pre-existing health conditions of Employee, his spouse or any eligible dependents; provided, however, that Company may discontinue any such coverage for which
it does not receive timely payment of Employee’s share of the cost due after the Separation Date; and provided further that, in each case, such continued participation is not prohibited by any applicable laws or would not otherwise jeopardize
the tax qualified status of any such programs. All payments or reimbursements under this Section 3.3 shall terminate upon commencement of new employment by Employee with an employer that offers health care coverage to its employees. If any such
continuing participation is prohibited by applicable law or would otherwise jeopardize the tax qualified status of any medical, dental or life insurance plan and, as a result, Company terminates any such coverage, it shall promptly reimburse
Employee (or Employee’s spouse and eligible dependents, as the case may be) for the cost of obtaining comparable third party coverage irrespective of any then preexisting health conditions of any of them who was covered immediately before the
Separation Date. The Company shall pay or reimburse Executive not less frequently than monthly an amount an amount equal to the cost of the benefits required to be provided under this Section 3.3. Any period of continuing coverage under this
Section 3.3 shall run at the same time as the applicable continuing coverage required to be offered to Employee, his spouse or eligible dependents under applicable laws; and each of them who has a right to continuing coverage under any such law
shall be deemed to have timely elected continuing coverage under such law, to the extent that Company is required to provide continuing coverage under this paragraph. 

Except as otherwise provided in this Section 3.3, the benefits to which Employee (or, as applicable, Employee’s spouse, eligible dependents or
estate) may be entitled upon termination of his employment, pursuant to the plans and policies of Company described in Article II of this Agreement, shall be determined and paid in accordance with such plans, policies and applicable laws. 

3.4. Surrender of Records and Property. Upon termination of Employee’s employment with Company, Employee shall deliver promptly to Company all
Confidential Information as defined in Section 4.1 and all Company property including, but not necessarily limited to records, manuals, books, blank forms, documents, letters, memoranda, business plans, minutes, notes, notebooks, reports,
computer disks, computer software, computer programs (including source code, object code, on line files, documentation, testing materials and plans and reports), computer print outs, member or customer lists, credit cards, keys, identification,
products, access cards, designs, drawings, sketches, devices, specifications, formulae, data, tables or calculations 

  
 8 

 
or copies thereof, and all other tangible or intangible property relating in any way to the business of Company that are the property of Company or any subsidiary or affiliate, if any, or which
relate in any way to the business, products, practices or techniques of Company or any subsidiary or affiliate. 
 ARTICLE IV. CONFIDENTIAL INFORMATION

 4.1. Definition. For purposes of this Agreement, “Confidential Information” means any information that is not generally known to the
public or to other persons who can obtain economic value from its disclosure or use; information which derives independent economic benefit from not being known to such persons; and information about the activities or business of Company that is not
generally known to others engaged in similar business or activities, its products, services, finances, trade secrets, contracts, patents filed or pending, the techniques used in completing customer projects, research and development, data and
information, processes, designs, engineering, marketing plans or techniques, organization or operation. The foregoing list is intended to be illustrative rather than comprehensive. Additionally, the term “confidential information” shall
mean any confidential information as that term is defined in any Agreement Company may have with its customers or other third parties from time to time. 

4.2. Nondisclosure. During the term of this Agreement or at any time thereafter, Employee agrees not to disclose Confidential information to any other
third party or company, other than in connection with Employee’s employment with Company, or use such information, directly or indirectly, for any purpose whatsoever, without the prior written consent of Company. 

ARTICLE V. INVENTIONS 
 5.1. Disclosure and Assignment
of Inventions and Other Works. During the term of this Agreement and for one year following the Separation Date, Employee shall promptly disclose to Company in writing all ideas, improvements and discoveries, whether or not such are patentable
or copyrightable, and whether or not in writing or reduced to practice (“Inventions”) and any writings, drawings, diagrams, charts, tables, databases, software (in object or source code and recorded on any medium), and any other works of
authorship, whether or not such are copyrightable (“Works of Authorship”) that are conceived, made, discovered, written or created by Employee alone or jointly with any person, group or entity, whether during the normal hours of his
employment at Company or on Employee’s own time. Employee hereby assigns all rights to all such Inventions and Works of Authorship to Company. Employee shall give Company all the assistance it reasonably requires for Company to perfect,
protect, and use its rights to such Inventions and Works of Authorship. Employee shall sign all such documents, take all such actions and supply all such information that Company considers necessary or desirable to transfer or record the transfer of
Company’s entire right, title and interest in such Inventions and Works of Authorship and to enable Company to obtain exclusive patent, copyright, or other legal protection for Inventions and Works of Authorship anywhere in the world, provided
Company shall bear all reasonable expenses of Employee in rendering such cooperation. 
 5.2. Notice and Acknowledgement. In accordance with
Minnesota Statute § 181.78, the foregoing Section 5.1 does not require Employee to assign or offer to assign to Company any of Employee’s rights in an Invention that Employee developed entirely on Employee’s own time

  
 9 

 
without using Company’s equipment, supplies, facilities or trade secret information, and (a) that does not relate directly to Company’s business or to Company’s actual or
demonstrably anticipated research or development, or (b) that does not result from any work performed by Employee for Company. For the purpose of this Section, “Company’s business” shall be defined as development pertaining to
implantable medical devices to treat obesity or devices to apply signals to a vagus nerve to treat a gastrointestinal disorder (e.g., obesity, pancreatitis or irritable bowel syndrome). 

To the extent a provision in this Agreement purports to require Employee to assign Inventions otherwise excluded by this paragraph, the provision is against
the public policy of the State of Minnesota and is unenforceable. By signing this Agreement, Employee acknowledges receipt of the notification required by Minnesota Statute § 181.78. 

ARTICLE VI. NONCOMPETITION AND NONSOLICITATION 
 6.1.
Agreement Not to Compete. During the Term of Employee’s employment by Company, and for a period of 12 consecutive months from the date of termination of such employment for whatever reason (whether occasioned by Employee or Company),
Employee shall not, directly or indirectly, in any geographical area in which the Company or its subsidiaries engage or plan to engage in its business, render services to any conflicting organization, or engage in competition with Company, in any
manner or capacity, nor direct any other individual or business enterprise to engage in, competition with Company in any manner or capacity, (e.g., as an advisor, principal, agent, partner, officer, director, stockholder of more than 3% of
the outstanding shares of the capital stock of a publicly traded company, employee, member of any association or limited liability company or otherwise) on any products competitive with Company’s existing products, any products competitive with
Company’s announced products or any products competitive with Company’s pending products that have not yet been announced but which Employee has, or should have, actual or constructive knowledge. For the purposes of this Section,
“conflicting organization” shall be defined as any person, corporation or entity that competes with any product, process or service, in existence or under development, of Company pertaining to implantable medical devices to treat obesity
or devices to apply signals to a vagus nerve to treat a gastrointestinal disorder (e.g., obesity, pancreatitis or irritable bowel syndrome). 
 6.2.
Agreement Not to Solicit. Employee hereby acknowledges that Company’s customers constitute vital and valuable aspects of its business on a worldwide basis. In recognition of that fact, for a period of one year following the termination
of this Agreement for any reason whatsoever, Employee shall not solicit, or assist anyone else in the solicitation of, any of Company’s then current customers to terminate their respective relationships with Company and to become customers of
any enterprise with which Employee may then be associated, affiliated or connected. 
 6.3. Agreement Not to Recruit. Employee hereby acknowledges
that Company’s employees, consultants and other contractors constitute vital and valuable aspects of its business and missions on a worldwide basis. In recognition of that fact, for a period of one year following the termination of this
Agreement for any reason whatsoever, Employee shall not solicit, or assist anyone else in the solicitation of, any of Company’s then current employees, consultants and 

  
 10 

 
other contractors to terminate their respective relationships with Company and to become employees, consultants and other contractors of any enterprise with which Employee may then be associated,
affiliated or connected. 
 ARTICLE VII. MISCELLANEOUS PROVISIONS 

7.1. Company Remedies. Employee acknowledges and agrees that the restrictions and agreements contained in this Agreement are reasonable and necessary to
protect legitimate interests of Company, that the services to be rendered by Employee are of a special, unique and extraordinary character, that it would be difficult to replace such services and that any violation of Articles IV, V or VI of
this Agreement would be highly injurious to Company, that Employee’s violation of any of Articles IV, V or VI of this Agreement would cause Company irreparable harm that would not be adequately compensated by monetary damages and that the
remedy at law for any breach of any of the provisions of Articles IV, V and VI will be inadequate. Accordingly, Employee specifically agrees that Company shall be entitled, in addition to any remedy at law, to seek preliminary and permanent
injunctive relief and specific performance for any actual or threatened violation of this Agreement and to enforce the provisions of Articles IV, V and VI of this Agreement. 

7.2. Assignment. This Agreement shall not be assignable, in whole or in part, by Employee without the written consent of Company and any purported or
attempted assignment or transfer of this Agreement or any of Employee’s duties, responsibilities or obligations hereunder shall be void. This Agreement shall inure to the benefit of and be binding upon Employee, Employee’s heirs and
personal representatives. This Agreement shall inure to the benefit of and be binding upon Company and its successors and assigns. Notwithstanding the foregoing, Company may not, without the written consent of Employee, assign its rights and
obligations under this Agreement to any business entity that has become the successor to Company in the event of a sale, merger, liquidation or similar transaction. After any such assignment by Company to which Employee has given such consent,
Company shall be discharged from all further liability hereunder and such successor assignee shall thereafter be deemed to be Company for the purposes of all provisions of this Agreement. 

7.3. Notices. All notices, requests, demands and other communications under this Agreement shall be in writing, shall be deemed to have been duly given
on the date of service if personally served on the parties to whom notice is to be given, or on the third day after mailing if mailed to the parties to whom notice is given, whether by first class, registered, or certified mail, and properly
addressed as follows: 
  

			
	If to Company, at:	  	EnteroMedics Inc.
		  	2800 Patton Road
		  	St. Paul, MN 55113
		
	If to Employee, at:	  	Dan W. Gladney
		  	100 Third Ave. So., Unit 2202
		  	Minneapolis, MN 55401

  
 11 

 Any party may change the address for the purpose of this Section by giving the other written notice of the new
address in the manner set forth above. 
 7.4. Governing Law. The validity, interpretation, performance and enforcement of this Agreement shall be
governed by the laws of the State of Minnesota, without regard to conflicts of laws principles thereof. 
 7.5. Arbitration. The parties irrevocably
consent that, except to the extent provided in the following sentence, any litigation or other dispute arising between the parties, in connection with the interpretation or enforcement of this Agreement, that has not been settled through negotiation
within a period of 30 days after the date on which either party shall first have notified the other party in writing of the existence of the dispute, shall be settled by final and binding arbitration under the then applicable Commercial
Arbitration Rules of the American Arbitration Association (“AAA”); and a court judgment on the award may be entered in any court having competent jurisdiction. Notwithstanding the foregoing, neither party shall be entitled or required to
seek arbitration regarding any cause of action that would entitle such party to injunctive relief. 
 Any such arbitration shall be conducted by one neutral
arbitrator appointed by mutual agreement of the parties or, failing such agreement, in accordance with the AAA Rules. The arbitrator shall be an experienced attorney with a background in employment law. Any arbitration shall be conducted in
Minneapolis, Minnesota. An arbitration award may be enforced in any court of competent jurisdiction. Notwithstanding any contrary provision in the AAA Rules, the following additional procedures and rules shall apply to any such arbitration: 

 

	 	(a)	Each party shall have the right to request from the arbitrator, and the arbitrator shall order upon good cause shown, reasonable and limited pre hearing discovery, including (i) exchange of witness lists,
(ii) depositions under oath of named witnesses at a mutually convenient location, (iii) written interrogatories, and (iv) document requests; 

  

	 	(b)	Upon conclusion of the pre hearing discovery, the arbitrator shall promptly hold a hearing upon the evidence to be adduced by the parties and shall promptly render a written opinion and award; 

 

	 	(c)	The arbitrator may award damages consistent with the terms of this Agreement but may not award or assess punitive damages against either party; and 

 

	 	(d)	Each party shall bear 50% of the fees and costs of the arbitrator, subject to the power of the arbitrator, in his or her sole discretion, to award all such fees and costs to the prevailing party. 

7.6. Construction. Notwithstanding the general rules of construction, both Company and Employee acknowledge that both parties were given an equal
opportunity to negotiate the terms and conditions contained in this Agreement, and agree that the identity of the drafter of this Agreement is not relevant to any interpretation of the terms and conditions of this Agreement. 

  
 12 

 It is intended that any amounts payable under this Agreement shall be exempt from or comply with the applicable
requirements of Code Section 409A, and the terms of this Agreement shall be interpreted in a manner that is consistent with and gives full effect to such intent. 

7.7. Severability. In the event any provision of this Agreement (or portion thereof) shall be held illegal or invalid for any reason, said illegality
or invalidity shall not in any way affect the legality or validity of any other provision of this Agreement. To the extent any provision (or portion thereof) of this Agreement shall be determined to be invalid or unenforceable in any jurisdiction,
such provision (or portion thereof) shall be deemed to be deleted from this Agreement as to such jurisdiction only, and the validity and enforceability of the remainder of such provision and of this Agreement shall be unaffected. 

7.8. Entire Agreement. Except for Employee’s Stock Option Agreements, this Agreement is the final, complete and exclusive agreement of the parties
and sets forth the entire agreement between Company and Employee with respect to Employee’s employment by Company, and there are no undertakings, covenants or commitments other than as set forth herein. The Agreement may not be altered or
amended, except by a writing executed by Employee and a member of the Board. 
 7.9. Survival. The parties expressly acknowledge and agree that the
provisions of this Agreement that by their express or implied terms extend beyond the expiration of this Agreement or the termination of Employee’s employment under this Agreement, shall continue in full force and effect, notwithstanding
Employee’s termination of employment under this Agreement or the expiration of this Agreement. 
 7.10. Waivers. No failure on the part of
either party to exercise, and no delay in exercising, any right or remedy under this Agreement shall operate as a waiver thereof; nor shall any single or partial exercise of any right or remedy under this Agreement preclude any other or further
exercise thereof or the exercise of any other right or remedy granted hereby or by any related document or by law. 
 7.11. Attorneys’ Fees for
Negotiating Agreement. Upon receipt by Company of a statement for legal services from the attorneys representing Employee, Company shall reimburse Employee or pay on behalf of Employee the reasonable and necessary attorneys’ fees and
associated expenses incurred by Employee in connection with the negotiation of this Agreement, provided, that such fees and expenses shall not exceed $5,000.00. 

7.12. Attorneys’ Fees for Resolving Disputes. If any party to this Agreement is made or shall become a party to any litigation (including
arbitration) commenced by or against the other party involving the enforcement of any of the rights or remedies of such party, or arising on account of a default of the other party in its performance of any of the other party’s obligations
hereunder, then the prevailing party in such litigation shall be entitled to receive from the other party all costs incurred by the prevailing party in such litigation, plus reasonable attorneys’ fees to be fixed by the court or arbitrator (as
applicable), with interest thereon from the date of judgment or arbitrator’s decision at the rate of 8% or, if less, the maximum rate permitted by law. 

[Signature page follows] 

  
 13 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
above written. 
  

			
	ENTEROMEDICS, INC.
		
	By	 	 /s/ Mark B. Knudson

	Name:	 	Mark B. Knudson, Ph.D.
	Its:	 	President and Chief Executive Officer

  

	
	 /s/ Dan W. Gladney

	  

	 Dan W. Gladney

 The undersigned member of the Compensation Committee of the Board hereby certifies that this Agreement has been duly
approved by resolutions of that Committee. 
  

	
	 /s/ Nicholas L. Teti, Jr.

	Nicholas L. Teti, Jr.

 [Signature Page to Employment Agreement] 

 GENERAL RELEASE 

This General Release is made and entered into as of the      day of
            , by Employee (“Employee”). 
 WHEREAS,
EnteroMedics Inc. (“Company’’) and Employee are parties to an Employment Agreement dated                 , 2015; 

WHEREAS, Employee intends to settle any und all claims that Employee has or may have against Company as a result of Employee’s
employment with Company and the cessation of Employee’s employment with Company; and 
 WHEREAS, Under the terms of the
Employment Agreement, which Employee agrees are fair and reasonable, Employee agreed to enter into this General Release as a condition precedent to the severance arrangements described in Article III of the Employment Agreement. 

NOW, THEREFORE, in consideration of the provisions and the mutual covenants herein contained, the parties agree as follows: 

1. Release. For the consideration expressed in the Employment Agreement, Employee does hereby fully and completely release and waive
any and all claims, complaints, causes of action, demands, suits and damages, of any kind or character, which Employee has or may have against the Released Parties, as hereinafter defined, arising out of any acts, omissions, conduct, decisions,
behavior or events occurring up through the date of Employee’s signature on this General Release, including Employee’s employment with Company and the cessation of that employment. For purposes of this General Release, “Released
Parties” means collectively Company, its predecessors, successors, assigns, parents, affiliates, subsidiaries, related companies, officers, directors, shareholders, agents, servants, employees and insurers, and each and all thereof. 

Employee understands and accepts that Employee’s release of claims includes any and all possible discrimination claims, including, but
not limited to, claims based upon: Title VII of the Federal Civil Rights Act of 1964, as amended; the Age Discrimination in Employment Act; the Americans with Disabilities Act; the Equal Pay Act; the Fair Labor Standards Act; the Employee
Retirement Income Security Act; the Minnesota Human Rights Act; Minn. Stat. §181.81; or any other federal, state or local statute, ordinance or law. Employee also understands that Employee is giving up all other claims, including those grounded
in contract or tort theories, including, but not limited to: wrongful discharge; violation of Minn. Stat. §176.82; breach of contract; tortious interference with contractual relations; promissory estoppel; breach of the implied covenant of good
faith and fair dealing; breach of express or implied promise; breach of manuals or other policies; assault; battery; fraud; false imprisonment; invasion of privacy; intentional or negligent misrepresentation; defamation, including libel, slander,
discharge defamation and self publication defamation; discharge in violation of public policy; whistleblower; intentional or negligent infliction of emotional distress; or any other theory, whether legal or equitable. 

Employee further understands that Employee is releasing, and does hereby release, any claims for damages, by charge or otherwise, whether
brought by Employee or on Employee’s behalf by any other party, governmental or otherwise, and agrees not to institute any claims for 

 
damages via administrative or legal proceedings against any of the Released Parties. Employee also waives and releases any and all rights to money damages or other legal relief awarded by any
governmental agency related to any charge or other claim against any of the Released Parties. 
 This General Release does not apply to
(i) any obligation of Company to provide benefits or payments to Employee under Article II or Article III of the Agreement, (ii) any post termination claim that Employee may have for benefits under the provisions of any employee benefit
plan maintained by Company, (iii) any rights Employee has pursuant to COBRA, (iv) any rights or claims that Employee may have as a shareholder of Company and/or (v) any rights of defense indemnification or contribution to which
Employee is entitled, whether pursuant to the Released Parties’ certificate of incorporation, bylaws, contract, applicable law or otherwise. 

2. Rescission. Employee has been informed of Employee’s right to rescind this General Release by written notice to Company within
15 calendar days after the execution of this General Release. Employee has been informed and understands that any such rescission must be in writing and delivered to Company by hand or sent by mail within the 15 day time period. If delivered by
mail, the rescission must be: (1) postmarked within the applicable period and (2) sent by certified mail, return receipt requested. 

Employee understands that Company will have no obligations under the Employment Agreement in the event a notice of rescission by Employee is
timely delivered, and, in the event Employee rescinds this General Release, Employee agrees to repay to Company any payments made to Employee or benefits conferred upon him pursuant to Article III of the Employment Agreement before the date of
rescission. 
 3. Acceptance Period; Advice of Counsel. The terms of this General Release will be open for acceptance by Employee for
a period of 21 days during which time Employee may consider whether or not to accept this General Release. Employee agrees that changes to this General Release, whether material or immaterial, will not restart this acceptance period. Employee
is hereby advised to seek the advice of an attorney regarding this General Release. 
 4. Binding Agreement. This General Release
shall be binding upon, and inure to the benefit of, Employee and Company and their respective successors and permitted assigns. 
 5.
Representation. Employee hereby acknowledges and states that Employee has read this General Release. Employee further represents that this General Release is written in language that is understandable to Employee, that Employee fully
appreciates the meaning of its terms, and that Employee enters into this General Release freely and voluntarily. 
 IN WITNESS
WHEREOF, Employee, after due consideration, has authorized, executed and delivered this General Release all as of the date first written. 
  

	
	  

	EmployeeExhibit_104

		
			 Exhibit 10.4
		

		
			
		

		
			 
		

		
			 
		

		
			September 14, 2015
		

		
			 
		

		
			Damian Artt
		

		
			 
		

		
			Dear Damian, 
		

		
			 
		

		
			On behalf of Mobile Iron, Inc. (the “Company”), I am pleased to offer you the full-time position of Senior Vice President of World Wide Sales.  Speaking for myself, as well as the other members of the Company’s management team, we are all very impressed with your credentials and we look forward to your future success in this position.
		

		
			 
		

		
			The terms of your new full-time position with the Company are as set forth below:
		

		
			 
		

		
			1.         Position.
		

		
			 
		

		
			(a)  Your position will be Senior Vice President of World Wide Sales working out of the Company’s headquarters office.
		

		
			 
		

		
			(b)  You agree to the best of your ability and experience that you will at all times loyally and conscientiously perform all of the duties and obligations required of and from you pursuant to the express and implicit terms hereof, and to the reasonable satisfaction of the Company.  During the term of your employment, you further agree that you will devote all of your business time and attention to the business of the Company, the Company will be entitled to all of the benefits and profits arising from or incident to all such work services and advice, you will not render commercial or professional services of any nature to any person or organization, whether or not for compensation, without the prior written consent of the Company, and you will not directly or indirectly engage or participate in any business that is competitive in any manner with the business of the Company.  Nothing in this letter agreement will prevent you from accepting speaking or presentation engagements in exchange for honoraria or from serving on boards of charitable organizations, or from owning no more than one percent (1%) of the outstanding equity securities of a corporation whose stock is listed on a national stock exchange.
		

		
			 
		

		
			2.         Start Date.  Subject to fulfillment of any conditions imposed by this letter agreement, you will commence this new position with the Company per your start date indicated below.
		

		
			 
		

		
			3.         Proof of Right to Work.  For purposes of federal immigration law, you will be required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States.  Such documentation must be provided to us within three business days of your date of hire, or our employment relationship with you may be terminated.
		

		
			 
		

		
			

		 

 

4.         Compensation.  You will be eligible to earn On-Target Earnings on an annualized basis in the amount of $660,000 which includes a base salary of $330,000 and an incentive bonus of $330,000 (which is equal to 100% of your base salary). You will be paid at the rate of $27,500 per month (which is equivalent to $330,000 on an annualized basis), less payroll deductions and withholdings, payable pursuant to the Company’s regular payroll practices. The incentive bonus will be based upon written objectives and financial targets that will be agreed upon between you and the Chief Executive Officer.
		

		
			 
		

		
			5.         Stock Option and RSU Grant.  In connection with the commencement of your employment and subject to the approval of the Company’s Board of Directors, you will be granted an option to purchase 150,000 shares (“Option Shares”) of Common Stock of the Company and granted 150,000 MobileIron restricted stock units (“MobileIron RSU’s”). The Option Shares will have an exercise price equal to the fair market value on the date of the grant.  The Option Shares will vest at the rate of 25% of the shares on the twelve (12) month anniversary of your Vesting Commencement Date (as defined in your Stock Option Agreement, which date will be your Start Date, as defined above) and the remaining Option Shares will vest monthly thereafter at the rate of 1/48 of the total number of the Option Shares per month, until either your Option Shares are fully vested or your employment ends, whichever occurs first.  The MobileIron RSUs will vest ratably over four years as follows:  (i) 25% of the total number of MobileIron RSUs will vest on the Quarterly Vesting Date (see below) that is in the same calendar quarter as the one year anniversary of your employment start date, and (ii) the remaining MobileIron RSUs will vest ratably with 6.25% of the total RSUs vesting on each subsequent Quarterly Vesting Date, until the MobileIron RSUs are totally vested, subject to your continued employment on each such Quarterly Vesting Date.  The Quarterly Vesting Dates are February 20, May 20, August 20, and November 20 of each year.  The Option Shares and MobileIron RSU’s will be subject to the terms of the Company’s 2014 Equity Incentive Plan and the MobileIron RSU Award Agreement, as applicable, between you and the Company. 
		

		
			 
		

		
			6.         Benefits.
		

		
			 
		

		
			(a)       Insurance Benefits.  The Company will provide you with the opportunity to participate in the standard benefits plans currently available to other Company employees, subject to any eligibility requirements imposed by such plans. 
		

		
			 
		

		
			(b)       Vacation; Sick Leave.   You will be entitled to paid time off according to the Company’s standard policies.
		

		
			 
		

		
			7.         Confidential Information and Invention Assignment Agreement/ Employee Handbook.   Your acceptance of this offer and commencement of employment with the Company is contingent upon your execution, and delivery to an officer of the Company, of the Company’s Confidential Information and Invention Assignment Agreement, a copy of which is enclosed for your review and execution (the “Confidentiality Agreement”), prior to or on your Start Date.  As a Company employee, you will be expected to abide by Company rules and policies, and acknowledge in writing that you have read the Company’s Employee Handbook. 
		

		
			 
		

		
			8.         At-Will Employment.  Your employment with the Company will be on an “at will” basis, meaning that either you or the Company may terminate your employment at any time and for any reason, with or without cause or advance notice. 
		

		
			 
		

		
			

		 

 

9.         No Conflicting Obligations.   You understand and agree that by accepting this offer of employment, you represent to the Company that your performance will not breach any other agreement to which you are a party and that you have not, and will not during the term of your employment with the Company, enter into any oral or written agreement in conflict with any of the provisions of this letter or the Company’s policies.  You are not to bring with you to the Company, or use or disclose to any person associated with the Company, any confidential or proprietary information belonging to any former employer or other person or entity with respect to which you owe an obligation of confidentiality under any agreement or otherwise.  The Company does not need and will not use such information and we will assist you in any way possible to preserve and protect the confidentiality of proprietary information belonging to third parties.  Also, we expect you to abide by any obligations to refrain from soliciting any person employed by or otherwise associated with any former employer and suggest that you refrain from having any contact with such persons until such time as any non-solicitation obligation expires.
		

		
			 
		

		
			10.       Background check. This offer is contingent upon a background check clearance.
		

		
			 
		

		
			11.       Entire Agreement.  This letter, together with the Confidentiality Agreement, sets forth the entire agreement and understanding between you and the Company with respect to your employment and supersedes all prior agreements and promises made to you by anyone, whether oral or written.  This letter (and your employment at will status) may not be modified or amended except by a written agreement, signed by an officer of the Company, although the Company reserves the right to modify unilaterally your work location, compensation, benefits, job title and duties, and reporting relationships.  This letter will be governed by the laws of the State of California without regard to its conflict of laws provision.
		

		
			 
		

		
			We are all delighted to be able to extend you this offer and look forward to working with you.  To indicate your acceptance of the Company’s offer, please sign and date this letter in the space provided below and return it to me, along with a signed and dated copy of the Confidentiality Agreement.  This offer will terminate if not accepted by you on or before September 15, 2015.
		

		
			 
		

		
			Very Truly Yours,
		

		
			 
		

		
			
		

		
			

		 

 

 
		

		
			MobileIron, Inc.
		

		
			 
		

			
					
						 

					
					
						 

				
	
					
						/s/ Bob Tinker

					
					
						 

				
	
					
						Signature

					
					
						 

				
	
					
						 

					
					
						 

				
	
					
						Bob Tinker – Chief Executive Officer

					
					
						 

				
	
					
						Printed Name and Title

					
					
						 

				
	
					
						 

					
					
						 

				
	
					
						September 14, 2015

					
					
						 

				
	
					
						Date

					
					
						 

				

		
			 
		

		
			 
		

		
			ACCEPTED AND AGREED:
		

		
			 
		

			
					
						/s/ Damian Artt

					
					
						 

				
	
					
						Employee Signature

					
					
						 

				
	
					
						 

					
					
						 

				
	
					
						September 14, 2015

					
					
						 

				
	
					
						Date

					
					
						 

				
	
					
						 

					
					
						 

				
	
					
						October 1, 2015

					
					
						 

				
	
					
						Start Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}]]